Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.400
0.00 (0.00%)
At close: Jul 3, 2025, 1:00 PM
2.390
-0.010 (-0.42%)
After-hours: Jul 3, 2025, 1:23 PM EDT
Daré Bioscience Market Cap
Daré Bioscience has a market cap or net worth of $21.24 million as of July 3, 2025. Its market cap has decreased by -51.73% in one year.
Market Cap
21.24M
Enterprise Value
14.48M
1-Year Change
-51.73%
Ranking
Category
Stock Price
$2.40
Market Cap Chart
Since April 10, 2014, Daré Bioscience's market cap has decreased from $98.00M to $21.24M, a decrease of -78.33%. That is a compound annual growth rate of -12.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 21.20M | -21.77% |
| Dec 31, 2024 | 27.10M | -11.15% |
| Dec 29, 2023 | 30.50M | -56.68% |
| Dec 30, 2022 | 70.40M | -54.05% |
| Dec 31, 2021 | 153.20M | 200.98% |
| Dec 31, 2020 | 50.90M | 271.53% |
| Dec 31, 2019 | 13.70M | 69.14% |
| Dec 31, 2018 | 8.10M | -38.17% |
| Dec 29, 2017 | 13.10M | -32.47% |
| Dec 30, 2016 | 19.40M | -74.67% |
| Dec 31, 2015 | 76.60M | -38.82% |
| Dec 31, 2014 | 125.20M | 27.76% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |